These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21187117)

  • 1. Detection of chimpanzee polyomavirus-specific antibodies in captive and wild-caught chimpanzees using yeast-expressed virus-like particles.
    Zielonka A; Verschoor EJ; Gedvilaite A; Roesler U; Müller H; Johne R
    Virus Res; 2011 Feb; 155(2):514-9. PubMed ID: 21187117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel polyomavirus detected in the feces of a chimpanzee by nested broad-spectrum PCR.
    Johne R; Enderlein D; Nieper H; Müller H
    J Virol; 2005 Mar; 79(6):3883-7. PubMed ID: 15731285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.
    Gedvilaite A; Zvirbliene A; Staniulis J; Sasnauskas K; Krüger DH; Ulrich R
    Viral Immunol; 2004; 17(1):51-68. PubMed ID: 15018662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.
    Franzén AV; Tegerstedt K; Holländerova D; Forstová J; Ramqvist T; Dalianis T
    In Vivo; 2005; 19(2):323-6. PubMed ID: 15796193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SV40-like polyomavirus infections in captive and free-ranging macaque species.
    Verschoor EJ; Niphuis H; Fagrouch Z; Christian P; Sasnauskas K; Pizarro MC; Heeney JL
    J Med Primatol; 2008 Aug; 37(4):196-201. PubMed ID: 18194222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
    Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
    J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.
    Gedvilaite A; Dorn DC; Sasnauskas K; Pecher G; Bulavaite A; Lawatscheck R; Staniulis J; Dalianis T; Ramqvist T; Schönrich G; Raftery MJ; Ulrich R
    Virology; 2006 Oct; 354(2):252-60. PubMed ID: 16904154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.
    Norkiene M; Stonyte J; Ziogiene D; Mazeike E; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2015 Aug; 15():68. PubMed ID: 26239840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.
    Sasnauskas K; Bulavaite A; Hale A; Jin L; Knowles WA; Gedvilaite A; Dargeviciūte A; Bartkeviciūte D; Zvirbliene A; Staniulis J; Brown DW; Ulrich R
    Intervirology; 2002; 45(4-6):308-17. PubMed ID: 12602348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological cross-reactions between four polyomaviruses of birds using virus-like particles expressed in yeast.
    Zielonka A; Gedvilaite A; Reetz J; Rösler U; Müller H; Johne R
    J Gen Virol; 2012 Dec; 93(Pt 12):2658-2667. PubMed ID: 22933666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast cells allow high-level expression and formation of polyomavirus-like particles.
    Sasnauskas K; Buzaite O; Vogel F; Jandrig B; Razanskas R; Staniulis J; Scherneck S; Krüger DH; Ulrich R
    Biol Chem; 1999 Mar; 380(3):381-6. PubMed ID: 10223341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological cross-reactivity between human polyomaviruses.
    Moens U; Van Ghelue M; Song X; Ehlers B
    Rev Med Virol; 2013 Jul; 23(4):250-64. PubMed ID: 23650080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point mutation in calcium-binding domain of mouse polyomavirus VP1 protein does not prevent virus-like particle formation, but changes VP1 interactions with Saccharomyces cerevisiae cell structures.
    Adamec T; Palková Z; Velková K; Stokrová J; Forstová J
    FEMS Yeast Res; 2005 Feb; 5(4-5):331-40. PubMed ID: 15691738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV polyomaviruses among the healthy blood donors.
    Šroller V; Hamšíková E; Ludvíková V; Musil J; Němečková Š; Saláková M
    J Med Virol; 2016 Jul; 88(7):1254-61. PubMed ID: 26630080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological cross reactivity between polyomavirus capsids.
    Viscidi RP; Clayman B
    Adv Exp Med Biol; 2006; 577():73-84. PubMed ID: 16626028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunodominant, cross-reactive B-cell epitope region is located at the C-terminal part of the hamster polyomavirus major capsid protein VP1.
    Siray H; Frömmel C; Voronkova T; Hahn S; Arnold W; Schneider-Mergener J; Scherneck S; Ulrich R
    Viral Immunol; 2000; 13(4):533-45. PubMed ID: 11192300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and biomedical applications of virus-like particles derived from polyomaviruses.
    Teunissen EA; de Raad M; Mastrobattista E
    J Control Release; 2013 Nov; 172(1):305-321. PubMed ID: 23999392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.